Did the Clinical Spectrum of Thromboangiitis Obliterans Change in the Past 40 Years?


Journal

Angiology
ISSN: 1940-1574
Titre abrégé: Angiology
Pays: United States
ID NLM: 0203706

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 23 4 2020
medline: 30 7 2020
entrez: 23 4 2020
Statut: ppublish

Résumé

Thromboangiitis obliterans (TAO) is an inflammatory disease that usually affects small and medium-sized arteries in the upper and lower limbs of young smokers. Previous studies showed that the spectrum TAO has changed in the 80s: the male-to-female ratio decreased, older patients were diagnosed, and upper limb involvement was more common. The aim of our study was to assess the changing clinical spectrum of TAO in France during the past 40 years. All consecutive patients fulfilling TAO's criteria between January 1967 and January 2016 were retrospectively included in 3 departments of internal medicine. We compared TAO features in patients diagnosed before and after 2002; 141 (77.5%) men and 41 (22.5%) women were included. Patients diagnosed after 2002 were older (37 [31-39] vs 34 [29-35] years

Identifiants

pubmed: 32319306
doi: 10.1177/0003319720920163
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

621-625

Auteurs

Simon Soudet (S)

Department of Internal Medicine, Hôpital HURIEZ, CHRU Lille, France.

Alexandre Le Joncour (A)

Department of Internal Medicine and Clinical Immunology, Centre de Référence des Maladies Auto-Immunes et Systémiques Rares, des Maladies Auto-Inflammatoires et de l'Amylose, Paris, France.
AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
Sorbonne Université, UPMC Univ Paris 06, UMR 7211, France.

Thomas Quemeneur (T)

Department of Nephrology and Internal Medicine, Valenciennes Hospital, France.

Helene Maillard (H)

Department of Internal Medicine, Hôpital HURIEZ, CHRU Lille, France.

Fabien Koskas (F)

Department of Vascular Surgery, Assistance Publique des Hôpitaux de Paris, Hôpital Pitié Salpêtrière, Paris, France.

Eric Hachulla (E)

Department of Internal Medicine, Hôpital HURIEZ, CHRU Lille, France.

Patrice Cacoub (P)

Department of Internal Medicine and Clinical Immunology, Centre de Référence des Maladies Auto-Immunes et Systémiques Rares, des Maladies Auto-Inflammatoires et de l'Amylose, Paris, France.
AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
Sorbonne Université, UPMC Univ Paris 06, UMR 7211, France.

Cecile M Yelnik (CM)

Department of Internal Medicine, Hôpital HURIEZ, CHRU Lille, France.

David Saadoun (D)

Department of Internal Medicine and Clinical Immunology, Centre de Référence des Maladies Auto-Immunes et Systémiques Rares, des Maladies Auto-Inflammatoires et de l'Amylose, Paris, France.
AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
Sorbonne Université, UPMC Univ Paris 06, UMR 7211, France.

Marc Lambert (M)

Department of Internal Medicine, Hôpital HURIEZ, CHRU Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH